Is agapentin (possibly a misspelling of a medication name) another name for pregabalin (lyrica)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gabapentin and Pregabalin: Different Medications in the Same Class

No, gabapentin and pregabalin are not the same medication - they are distinct but related drugs in the same medication class (calcium channel α2-δ ligands). 1

Similarities Between Gabapentin and Pregabalin

  • Both are calcium channel α2-δ ligands that are structurally related to GABA (gamma-aminobutyric acid) 1, 2
  • Both are primarily used for treatment of neuropathic pain conditions and as adjunctive therapy for seizures 1, 2
  • Both medications have similar side effect profiles, with dizziness and somnolence being the most common adverse effects 3, 2
  • Both drugs are eliminated primarily unchanged through the kidneys, requiring dose adjustments in renal impairment 3, 2

Key Differences Between Gabapentin and Pregabalin

  • Pregabalin (brand name Lyrica) has linear pharmacokinetics, while gabapentin has nonlinear absorption 2, 4
  • Pregabalin has higher bioavailability (approximately 90%) compared to gabapentin 4
  • Pregabalin reaches therapeutic doses more quickly and at lower doses than gabapentin 5
  • Pregabalin is FDA-approved for diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and neuropathic pain associated with spinal cord injury, while gabapentin is only FDA-approved for postherpetic neuralgia (for pain indications) 6
  • Pregabalin is classified as a Schedule V controlled substance due to potential for abuse and dependence, while gabapentin is not federally scheduled (though some states regulate it) 2

Clinical Effectiveness Comparison

  • In studies of patients with postherpetic neuralgia, patients prescribed pregabalin were more likely to reach therapeutic doses with their first prescription (69.0%) compared to those prescribed gabapentin (3.5%) 5
  • A higher proportion of patients reached therapeutic doses by their third consecutive prescription with pregabalin (89.3%) compared to gabapentin (46.2%) 5
  • Some evidence suggests that opioid use decreased after initiation of pregabalin but increased after initiation of gabapentin in patients with postherpetic neuralgia 5

Dosing Considerations

  • Gabapentin starting dose: 100-300 mg at bedtime or 100-300 mg three times daily, with titration by 100-300 mg every 1-7 days as tolerated 1, 7
  • Pregabalin starting dose: 50 mg three times daily or 75 mg twice daily, with increases to 300 mg/day after 3-7 days 1
  • Maximum doses: Gabapentin up to 3600 mg/day; Pregabalin up to 600 mg/day 1, 7
  • Both medications require lower starting doses and slower titration in elderly patients 3, 7

Common Precautions for Both Medications

  • Both are contraindicated in pregnancy or when actively trying to conceive 3
  • Both require dose adjustments in renal impairment 3, 2
  • Both can cause dizziness and somnolence (23-46% and 15-25% of patients respectively) 3
  • Both can cause peripheral edema (approximately 10% of patients) 3
  • Both should be tapered gradually rather than discontinued abruptly 7

While these medications are often used interchangeably in clinical practice for similar indications, they are distinct pharmaceutical agents with important differences in pharmacokinetics, dosing, and regulatory status.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pregabalin: an antiepileptic agent useful for neuropathic pain.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007

Guideline

Contraindications and Precautions for GABA Neurotransmitter Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pregabalin: a new agent for the treatment of neuropathic pain.

Drugs of today (Barcelona, Spain : 1998), 2005

Guideline

Gabapentin Dosage and Administration for Parkinson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.